Ally Bridge LB Healthcare Master Fund SC 13D Sciclone Pharmaceuticals Inc

Exhibit 7.01

JOINT FILING AGREEMENT

THIS JOINT FILING AGREEMENT is entered into as of February 22, 2016, by and among the parties hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the common stock, par value $0.001 per share, of SciClone Pharmaceuticals, Inc. and any amendment thereto signed by each of the undersigned shall be filed on behalf of each undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.

Ally Bridge LB Healthcare Master Fund Limited
By:	/s/ Bin Li
	Name: Bin Li Title:   Director
Ally Bridge LB Management Limited
By:	/s/ Bin Li
	Name: Bin Li Title:   Director
ABG Management Limited
By:	/s/ Fan Yu
	Name: Fan Yu Title:   Director
Fan Yu
By:	/s/ Fan Yu
Bin Li
By;	/s/ Bin Li